KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

KORU Medical Systems, Inc.NASDAQ: KRMD

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin widens to -7.4%

Operating margin was -7.4% in Q1 FY2026, up 5.6 pp from a year earlier. On a trailing-twelve-month basis it was -6.0%, up 10.3 pp year over year. Over 3 fiscal years it widened by 31.4 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 3 analysts of -0.7% for the fiscal year ending Dec 2026, up from -7.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-7.4%-2.3 pp QoQ
Last fiscal yearDec 2025
-7.2%+11.9 pp YoY
LTMMar 2026
-6.0%+10.3 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.6 pp-2.3 pp-7.8 pp
1 year+11.9 pp+6.5 pp-5.4 pp
3 years+31.4 pp+16.7 pp-14.8 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-7.2%
Year-over-year change
+11.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How KRMD compares with its peers on the latest reported figures

  • KRMD's LTM Mar 2026 operating margin of -6.0% is the 3rd highest of the 10 companies compared; the peer median is -62.4%.
  • Its year-over-year change of +10.3 pp is the 7th highest of 10, against a peer median of +23.9 pp.
  • Over three fiscal years its change of +31.4 pp compares with a peer median of +32.8 pp.
KRMD Competitors Peer median
Operating Margin for KRMD and competitors
Company Period LTM level YoY 3-year change
UTMDUtah Medical Products, Inc.LTM Mar 202628.8% -3.9 pp-8.3 pp
INFUInfuSystem Holdings, Inc.LTM Mar 20269.1% +3.0 pp+6.8 pp
KRMDKORU Medical Systems, Inc.LTM Mar 2026-6.0% +10.3 pp+31.4 pp
STIMNeuronetics, Inc.LTM Mar 2026-19.4% +23.9 pp+32.8 pp
PREPrenetics Global LimitedLTM Mar 2026-33.7% +85.8 pp+460.3 pp
TLSITriSalus Life Sciences, Inc.LTM Mar 2026-62.4% +36.6 pp+234.2 pp
OSUROraSure Technologies, Inc.LTM Mar 2026-64.6% -42.7 pp-57.9 pp
MXCTMaxCyte, Inc.LTM Mar 2026-119.7% +16.2 pp-75.3 pp
PROFProfound Medical Corp.LTM Mar 2026-203.2% +434.5 pp+224.6 pp
NYXHNyxoah S.A.LTM Mar 2026-527.2% +1013.5 pp+226.0 pp
Peer median (excluding KRMD) -62.4%+23.9 pp+32.8 pp

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.